Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Accepts healthy volunteers

Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

ClinicalTrials.gov ID: NCT04350138

Public ClinicalTrials.gov record NCT04350138. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Observer-Blind, Placebo-Controlled Study, to Assess the Efficacy of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) in Preventing Gonococcal Infection

Study identification

NCT ID
NCT04350138
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
2,606 participants

Conditions and interventions

Interventions

  • Meningococcal Group B Vaccine Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 28, 2020
Primary completion
Feb 17, 2026
Completion
Sep 30, 2026
Last update posted
Apr 13, 2026

2020 – 2026

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
University of Alabama at Birmingham School of Medicine - Infectious Disease Birmingham Alabama 35294
UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles California 90035
SFDPH Bridge HIV Center San Francisco California 94102
Emory University School of Medicine - The Ponce de Leon Center Atlanta Georgia 30303
Emory University Hospital Midtown - Emory Clinic Infectious Diseases Atlanta Georgia 30308
University of Illinois at Chicago College of Medicine - Division of Infectious Diseases Chicago Illinois 60612
LSU - CrescentCare Sexual Health Center New Orleans Louisiana 70119
Walter Reed National Military Medical Center Bethesda Maryland 20889
Harlem Prevention Center, Columbia University, Mailman School of Public Health New York New York 10027
University of Pennsylvania HIV/AIDS Prevention Research Division Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04350138, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04350138 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →